iSpecimen stockholders authorize reverse split; director Ross resigns

iSpecimen Inc.

Director Andrew L. Ross resigns effective July 25, 2024; no disagreement with management.
Stockholders approved amendment to authorize reverse stock split at ratio 1:10 to 1:20, at Board's discretion.
Tracy Curley and Elizabeth A. Graham elected as Class III directors for three-year terms.
Wolf & Company ratified as independent auditor for FY2024.
All proposals passed; reverse split filing timing at Board's discretion.

item 5.02 item 5.07

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Andrew L. Ross

director

ISPC · iSpecimen Inc.

Effective: 2024-07-25
Filed: July 22, 2024, 7:59 PM ET

On July 17, 2024, iSpecimen Inc. (the “Company”) received a written notice from Andrew L. Ross that he will be resigning as a director of the Company, effective July 25, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Andrew L. Ross resigned as director at iSpecimen Inc..

Action: resigned
Role: director

Exact text from the filing

On July 17, 2024, iSpecimen Inc. (the “Company”) received a written notice from Andrew L. Ross that he will be resigning as a director of the Company, effective July 25, 2024.

View on SEC.gov

iSpecimen Inc. filing history →

Source: SEC EDGAR

accession 0001104659-24-081547

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.